1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-227.
3. Malone FD, Wald NJ, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes KA, Bianchi DW, Rudnicka A, Hackshaw A, Lambert-Messerlian G, D'Alton ME. First- and Second-trimester Evaluation of Risk (FASTER) trial: principal results of the NICHD Multicenter Down Syndrome Screening Study. Am J Obstet Gynecol 2003;189:S56.
4. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-894.
5. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-630.
6. Saller DN Jr, Canick JA, Oyer CE. The detection of non-immune hydrops through second-trimester maternal serum screening. Prenat Diagn 1996;16:431-435.
7. Jorgensen PI, Trolle D. Low urinary oestriol excretion during pregnancy in women giving birth to infants with Down's syndrome. Lancet 1972;2:782-784.
8. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988;95:330-333.
11. Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992;12:801-806.
12. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446-1451.
13. Wapner RJ. First trimester screening: the BUN study. Semin Perinatol 2005;29:236-239.
15. Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 2005;29:252-257.
16. Choi YK, Kim MY, Han JY, Ryu HM, Yang JH, Kim ES, Lee HB, Han IS, Ko MI, Han HW. A study about the effectiveness of triple marker test as a screening test for chromosomal aneuploidy. Korean J Obstet Gynecol 1999;42:1935-1942.
17. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-1534.